The Incidence of Central Serous Chorioretinopathy after Photorefractive Keratectomy and Laser In Situ Keratomileusis

Table 1

Baseline and clinical data of CSCR patients with a history of LASIK or PRK.

Patient	Gender; age	LASIK or PRK	Pre-LASIK or PRK Manifest Refraction	Location of surgery	Time of CSCR onset after LASIK or PRK	CSCR involv-; ement	CSCR therapy	UDVA at onset of CSCR	BCVA at onset of CSCR	Final UDVA	Final BCVA
1	M; 37	PRK	−4.50 sphere	Moran	19 days	OS	Observe	20/40	20/40	20/20	20/20
2	M; 28	PRK	−4.75 + 1.75 × 90	Outside	1 month	OS	Observe	20/20	20/20	20/15	Unknown
Wang et al. [7]	M; 50	LASIK	+0.5 − 1.25 × 155	Singapore	1 week	OD	Laser	Unknown	20/40	20/20	20/20
Haimovici et al. [8]	M; 54	LASIK	−7.00 − 1.00 × 180; −6.75 − 1.25 × 175	Greece	1 month	OU	PDT	Unknown	20/50; 20/50	Unknown	20/30; 20/25
Lim et al. [9]	M; 33	LASIK	+4.75 − 0.75 × 160; +6.25 − 2.00 × 180	India	4 days	OU	Observe	20/200; 20/125	20/125; 20/50	Unknown	20/30; 20/30
Sighvi et al. [10]	F; 20	LASIK	−7.00 + 1.00 × 90	Saudi Arabia	1 week	OD	PDT	Unknown	20/200	Unknown	20/60

M: Male; F: Female; PRK: Photoreactive Keratectomy; LASIK: Laser-assisted in situ keratomileusis; PDT: Photodynamic Therapy; Laser: Focal Photocoagulation; OD: Right Eye; OS: Left Eye; OU: Both Eyes; UDVA: Uncorrected distance visual acuity, BCVA: Best corrected visual acuity. Final UDVA and BCVA were from the last recorded follow-up visit.